8-K: Global Medical REIT Reports Q3 Loss, Boosts FFO, Extends Debt

Global Medical REIT Inc. announced a net loss for Q3 2025 due to an impairment charge, but reported increased FFO and AFFO, and successfully extended its credit facility maturities.

Summary

• Net loss attributable to common stockholders was $6.0 million, or $0.45 per diluted share, for Q3 2025, compared to net income of $1.8 million, or $0.14 per diluted share, in the prior year period.
• The net loss was primarily due to a $6.3 million impairment charge on an unoccupied health system administrative use facility in Aurora, IL, which was subsequently sold.
• Funds from operations (FFO) increased 4% year-over-year on a per share and unit basis to $14.5 million, or $1.00 per share and unit.
• Adjusted funds from operations (AFFO) increased 4% year-over-year on a per share and unit basis to $16.2 million, or $1.12 per share and unit.
• Same-store cash net operating income (Same-Store Cash NOI) grew 2.7% year-over-year.
• Rental revenue for Q3 2025 increased 8.4% year-over-year to $37.0 million.
• Completed a one-for-five reverse stock split on September 19, 2025, reducing outstanding shares from 67.0 million to 13.4 million.
• Established a $50 million common stock repurchase program in August 2025, with no shares repurchased as of November 3, 2025.
• Amended and restated its credit facility in October 2025, extending the maturity of the $400 million revolver to October 2029 (with options to October 2030) and the $350 million Term Loan A into tranches maturing between October 2029 and April 2031.
• Narrowed full year 2025 AFFO per share and unit guidance to $4.50 to $4.60 from $4.45 to $4.65.

Sentiment

Score: 7

Explanation: Despite a net loss driven by a one-time impairment, the operational metrics (FFO, AFFO, Same-Store NOI growth) are positive. The significant extension of debt maturities and the establishment of a share repurchase program are strong strategic moves that enhance financial stability and shareholder value, outweighing the temporary accounting loss.

Positives

• FFO increased to $14.5 million ($1.00 per share and unit) in Q3 2025, a 4% year-over-year increase on a per share and unit basis.
• AFFO increased to $16.2 million ($1.12 per share and unit) in Q3 2025, a 4% year-over-year increase on a per share and unit basis.
• Same-Store Cash NOI growth was 2.7% year-over-year.
• Rental revenue increased 8.4% year-over-year to $37.0 million.
• Successfully amended and restated its credit facility, extending maturities of the revolver and Term Loan A components, significantly improving the debt maturity profile from 1.3 years to 4.4 years.
• Established a $50 million common stock repurchase program, signaling confidence in valuation.
• Portfolio leased occupancy remained strong at 95.2% as of September 30, 2025.
• Weighted average lease term for the portfolio is 5.3 years with weighted average annual rent escalations of 2.1%.
• Borrowing capacity under the credit facility was $171 million as of November 3, 2025.

Negatives

• Net loss attributable to common stockholders was $6.0 million, or $0.45 per diluted share, for Q3 2025, compared to net income of $1.8 million, or $0.14 per diluted share, in the comparable prior year period.
• Recognized a $6.3 million impairment charge related to an unoccupied health system administrative use facility in Aurora, IL.
• Total expenses increased to $36.3 million in Q3 2025 from $32.7 million in Q3 2024, driven by higher general and administrative costs (including reverse stock split costs) and increased interest expense.
• Interest expense increased to $8.2 million in Q3 2025 from $7.2 million in Q3 2024, due to higher average borrowings and higher interest rates.

Risks

• Actual financial results could differ materially from projected or assumed forward-looking statements.
• Uncertainty regarding the ability to refinance indebtedness.
• Future economic conditions or performance may adversely affect results.
• Risks related to tenant ability to pay rent.
• Expectations are based on assumptions that are subject to change, many of which are outside of the company's control.

Future Outlook

The company narrowed its full year 2025 Adjusted Funds from Operations (AFFO) per share and unit guidance range to $4.50 to $4.60, from the previous range of $4.45 to $4.65. This guidance assumes no additional acquisitions or dispositions beyond those already completed or announced, and no further equity or debt issuances other than normal revolving credit facility borrowing and repayments.

Management Comments

• The current quarter net loss primarily resulted from a $6.3 million impairment charge recognized during the quarter related to our facility in Aurora, IL, an unoccupied health system administrative use facility, which was subsequently sold during the quarter.
• The increase in rental revenue primarily resulted from the impact of acquisitions that were completed subsequent to September 30, 2024, partially offset by dispositions during that period.
• The increase in total expenses reflects increased general and administrative costs, including costs related to the Reverse Stock Split, increased interest expense, as well as increased expenses related to the company’s acquisitions that were completed subsequent to September 30, 2024, partially offset by dispositions during that period.
• The increase in interest expense was primarily due to higher average borrowings and higher interest rates during the three months ended September 30, 2025, compared to the prior year period.

Industry Context

The medical real estate sector continues to demonstrate resilience, with Global Medical REIT's strong occupancy rate of 95.2% reflecting the stable demand for healthcare facilities. The company's focus on net-lease properties to physician groups and healthcare systems aligns with broader industry trends favoring specialized, long-term real estate assets in the healthcare sector. The successful extension of debt maturities is a critical move in the current higher interest rate environment, providing financial stability and flexibility, a common challenge for REITs.

Comparison to Industry Standards

• The portfolio's weighted average cap rate of 8.1% is competitive within the medical office building (MOB) and healthcare facility REIT sector, often compared to peers like Physicians Realty Trust (DOC), Healthcare Realty Trust (HR), or Ventas (VTR), though specific project-level comparisons are not provided in the filing.
• The 2.7% Same-Store Cash NOI growth is a solid performance indicator, generally in line with or slightly above the average for well-managed healthcare REITs, which typically aim for 2-3% annual growth in this metric.
• The extended weighted-average debt term of 4.4 years post-amendment improves the company's debt profile, moving it closer to industry averages for REITs which often seek longer-term, staggered debt maturities to mitigate refinancing risk.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact from increased FFO/AFFO, Same-Store Cash NOI growth, and the establishment of a share repurchase program. The reverse stock split aims to increase per-share metrics and potentially stock price. The dividend payments provide direct returns.
• Creditors: Positive impact from the extension of debt maturities, reducing near-term refinancing risk and improving the company's debt profile.
• Employees: Mark Decker, Jr.'s appointment as CEO, President, and Board member could signal new strategic direction.
• Tenants: Stable portfolio occupancy at 95.2% suggests continued strong demand for the company's medical facilities.

Next Steps

• Host a live webcast and conference call on November 5, 2025, at 9:00 a.m. Eastern Time to discuss results.
• Continue to operate under the amended and restated credit facility, with new interest rate swaps effective May 2026.
• Potentially repurchase shares under the $50 million common stock repurchase program.

Key Dates

Recommendation

While the company reported a net loss due to a one-time impairment, its core operational metrics like FFO, AFFO, and Same-Store Cash NOI showed healthy year-over-year growth. The successful amendment and extension of the credit facility significantly de-risks the balance sheet and provides long-term financial stability, which is a strong positive in the current market. The establishment of a share repurchase program also signals management's confidence. However, the net loss, even if impairment-driven, and the increase in interest expense warrant a cautious approach. The stock has undergone a reverse split, which can sometimes create volatility. Given the mix of strong operational performance and strategic de-risking against a one-time loss, a 'hold' recommendation is appropriate, allowing investors to observe the sustained impact of the debt restructuring and share repurchase program on future performance and valuation.

Keywords

Medical REIT, Healthcare Real Estate, GMRE, REIT, Financial Results, Earnings, FFO, AFFO, Net Operating Income, Credit Facility, Debt Extension, Reverse Stock Split, Share Repurchase Program, Medical Facilities, Portfolio Occupancy